194 related articles for article (PubMed ID: 37247567)
1. Game of Omes: ribosome profiling expands the MHC-I immunopeptidome.
Holly J; Yewdell JW
Curr Opin Immunol; 2023 Aug; 83():102342. PubMed ID: 37247567
[TBL] [Abstract][Full Text] [Related]
2. MHC Class I Immunopeptidome: Past, Present, and Future.
Yewdell JW
Mol Cell Proteomics; 2022 Jul; 21(7):100230. PubMed ID: 35395404
[TBL] [Abstract][Full Text] [Related]
3. The biogenesis of the immunopeptidome.
Admon A
Semin Immunol; 2023 May; 67():101766. PubMed ID: 37141766
[TBL] [Abstract][Full Text] [Related]
4. The impact of immunopeptidomics: From basic research to clinical implementation.
Shapiro IE; Bassani-Sternberg M
Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
[TBL] [Abstract][Full Text] [Related]
5. The interdependence of machine learning and LC-MS approaches for an unbiased understanding of the cellular immunopeptidome.
Nielsen M; Ternette N; Barra C
Expert Rev Proteomics; 2022 Feb; 19(2):77-88. PubMed ID: 35390265
[TBL] [Abstract][Full Text] [Related]
6. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
[TBL] [Abstract][Full Text] [Related]
7. Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation.
Trentini DB; Pecoraro M; Tiwary S; Cox J; Mann M; Hipp MS; Hartl FU
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4099-4108. PubMed ID: 32047030
[TBL] [Abstract][Full Text] [Related]
8. Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.
Jappe EC; Kringelum J; Trolle T; Nielsen M
Immunology; 2018 Jul; 154(3):407-417. PubMed ID: 29446062
[TBL] [Abstract][Full Text] [Related]
9. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
10. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
[TBL] [Abstract][Full Text] [Related]
11. Critical Review of Existing MHC I Immunopeptidome Isolation Methods.
Kuznetsov A; Voronina A; Govorun V; Arapidi G
Molecules; 2020 Nov; 25(22):. PubMed ID: 33228004
[TBL] [Abstract][Full Text] [Related]
12. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome.
Kaabinejadian S; Barra C; Alvarez B; Yari H; Hildebrand WH; Nielsen M
Front Immunol; 2022; 13():835454. PubMed ID: 35154160
[TBL] [Abstract][Full Text] [Related]
13. Variations in MHC class I antigen presentation and immunopeptidome selection pathways.
Zaitoua AJ; Kaur A; Raghavan M
F1000Res; 2020; 9():. PubMed ID: 33014341
[TBL] [Abstract][Full Text] [Related]
14. Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design.
Jappe EC; Garde C; Ramarathinam SH; Passantino E; Illing PT; Mifsud NA; Trolle T; Kringelum JV; Croft NP; Purcell AW
Nat Commun; 2020 Dec; 11(1):6305. PubMed ID: 33298915
[TBL] [Abstract][Full Text] [Related]
15. Tapasin-mediated editing of the MHC I immunopeptidome is epitope specific and dependent on peptide off-rate, abundance, and level of tapasin expression.
Boulanger DSM; Douglas LR; Duriez PJ; Kang Y; Dalchau N; James E; Elliott T
Front Immunol; 2022; 13():956603. PubMed ID: 36389776
[TBL] [Abstract][Full Text] [Related]
16. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
Zhang X; Qi Y; Zhang Q; Liu W
Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
[TBL] [Abstract][Full Text] [Related]
17. Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition.
Stopfer LE; Mesfin JM; Joughin BA; Lauffenburger DA; White FM
Nat Commun; 2020 Jun; 11(1):2760. PubMed ID: 32488085
[TBL] [Abstract][Full Text] [Related]
18. Peptide Channeling: The Key to MHC Class I Immunosurveillance?
Yewdell JW; Dersh D; Fåhraeus R
Trends Cell Biol; 2019 Dec; 29(12):929-939. PubMed ID: 31662235
[TBL] [Abstract][Full Text] [Related]
19. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
Li L; Batliwala M; Bouvier M
J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
[TBL] [Abstract][Full Text] [Related]
20. Contemplating immunopeptidomes to better predict them.
Gfeller D; Liu Y; Racle J
Semin Immunol; 2023 Mar; 66():101708. PubMed ID: 36621290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
